DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Utzschneider KM, Tong J, Montgomery B, Udayasankar J, Gerchman F, Marcovina SM, Watson CE, Ligueros-Saylan MA, Foley JE, Holst JJ, Deacon CF, Kahn SE.
The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose.
Diabetes Care 2008; 31: 108-113
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.